Axcan Pharma Inc.
TSX : AXP
NASDAQ : AXCA

Axcan Pharma Inc.

March 23, 2007 12:00 ET

Axcan Pharma to Present at the Scotia Capital Spring Growth Conference in Montreal

MONT-SAINT-HILAIRE, QUEBEC--(CCNMatthews - March 23, 2007) - Axcan Pharma Inc. ("Axcan" or the "Company")(NASDAQ:AXCA)(TSX:AXP) today announced that on Thursday, March 29, 2007, President and Chief Executive Officer, Frank Verwiel, M.D., will present an overview of the Company at the Scotia Capital Spring Growth Conference to be held in Montreal, QC. This presentation will take place at 9:00 a.m. local time.

A webcast of Axcan's presentation will also be accessible via the Company's website at www.axcan.com.

Axcan is a leading multinational specialty pharmaceutical company focused on gastroenterology. The company develops and markets a broad line of prescription products to treat a range of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to pancreatic insufficiency. Axcan's products are marketed by its own specialized sales forces in North America and Europe. Its common shares are listed on the NASDAQ Global Market under the symbol "AXCA" and on the Toronto Stock Exchange under the symbol "AXP".

Contact Information

  • Axcan Pharma Inc.
    Isabelle Adjahi
    Senior Director, Investor Relations and Communications
    450-467-2600 ext. 2000
    www.axcan.com